Menu
View Cart  

Columbia Scientific Development, LLC - June 7, 2017

$117.00
Procedures for receiving, reviewing, and evaluating complaints by a formally designated unit have not been adequately established.

Related Products

Building a CMC Scorecard for Drug Development Risk Assessment - Webinar CD/Transcript

Measuring Suicidality in Clinical Trials - Webinar CD/Transcript

New Medical Device and In Vitro Diagnostic Regulation in the EU - Webinar CD/Transcript

Related Events

De Novo Strategies for Getting Your Medical Device Approved: What is the FDA Really Looking For?

Medical Device Complaint Management: Follow the Outcomes for Regulatory Compliance

The CDER Reorganization: What It Means for Drugmakers

Search the Store

Shop by Category

Shop by Media